These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23385635)

  • 1. Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings.
    Cigna D; D'Anna C; Zizzo C; Francofonte D; Sorrentino I; Colomba P; Albeggiani G; Armini A; Bianchi L; Bini L; Duro G
    Mol Biosyst; 2013 Jun; 9(6):1162-8. PubMed ID: 23385635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentially expressed proteins in ER+ MCF7 and ER- MDA- MB-231 human breast cancer cells by RhoGDI-α silencing and overexpression.
    Hooshmand S; Ghaderi A; Yusoff K; Thilakavathy K; Rosli R; Mojtahedi Z
    Asian Pac J Cancer Prev; 2014; 15(7):3311-7. PubMed ID: 24815488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma LysoGb3: A useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes.
    Nowak A; Mechtler TP; Desnick RJ; Kasper DC
    Mol Genet Metab; 2017; 120(1-2):57-61. PubMed ID: 27773586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of blood Gb3 deposits as a new tool for diagnosis and therapy monitoring in patients with classic Fabry disease.
    Üçeyler N; Böttger J; Henkel L; Langjahr M; Mayer C; Nordbeck P; Wanner C; Sommer C
    J Intern Med; 2018 Oct; 284(4):427-438. PubMed ID: 29974530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabry disease: perspectives of urinary proteomics.
    Cuccurullo M; Beneduci A; Anand S; Mignani R; Cianciaruso B; Bachi A; Capasso G
    J Nephrol; 2010; 23 Suppl 16():S199-212. PubMed ID: 21170881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early markers of Fabry disease revealed by proteomics.
    Matafora V; Cuccurullo M; Beneduci A; Petrazzuolo O; Simeone A; Anastasio P; Mignani R; Feriozzi S; Pisani A; Comotti C; Bachi A; Capasso G
    Mol Biosyst; 2015 Jun; 11(6):1543-51. PubMed ID: 25666440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-α links heat and inflammation with Fabry pain.
    Üçeyler N; Urlaub D; Mayer C; Uehlein S; Held M; Sommer C
    Mol Genet Metab; 2019 Jul; 127(3):200-206. PubMed ID: 31221509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple method for quantification of plasma globotriaosylsphingosine: Utility for Fabry disease.
    Talbot A; Nicholls K; Fletcher JM; Fuller M
    Mol Genet Metab; 2017 Sep; 122(1-2):121-125. PubMed ID: 28847675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical potential of blood-proteomics in multiple sclerosis.
    De Masi R; Pasca S; Scarpello R; Idolo A; De Donno A
    BMC Neurol; 2013 May; 13():45. PubMed ID: 23692923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis unveils Gb3-independent alterations and mitochondrial dysfunction in a gla
    Elsaid HOA; Rivedal M; Skandalou E; Svarstad E; Tøndel C; Birkeland E; Eikrem Ø; Babickova J; Marti HP; Furriol J
    J Transl Med; 2023 Sep; 21(1):591. PubMed ID: 37670295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy.
    Heo SH; Kang E; Kim YM; Go H; Kim KY; Jung JY; Kang M; Kim GH; Kim JM; Choi IH; Choi JH; Jung SC; Desnick RJ; Yoo HW; Lee BH
    J Med Genet; 2017 Nov; 54(11):771-780. PubMed ID: 28835480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Globotriaosylceramide-induced reduction of K
    Rickert V; Kramer D; Schubert AL; Sommer C; Wischmeyer E; Üçeyler N
    Exp Neurol; 2020 Feb; 324():113134. PubMed ID: 31778662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the plasma proteomic profile of Fabry disease: Potential sex- and clinical phenotype-specific biomarkers.
    López-Valverde L; Vázquez-Mosquera ME; Colón-Mejeras C; Bravo SB; Barbosa-Gouveia S; Álvarez JV; Sánchez-Martínez R; López-Mendoza M; López-Rodríguez M; Villacorta-Argüelles E; Goicoechea-Diezhandino MA; Guerrero-Márquez FJ; Ortolano S; Leao-Teles E; Hermida-Ameijeiras Á; Couce ML
    Transl Res; 2024 Jul; 269():47-63. PubMed ID: 38395389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Globotriaosylsphingosine (Lyso-Gb
    Alharbi FJ; Baig S; Auray-Blais C; Boutin M; Ward DG; Wheeldon N; Steed R; Dawson C; Hughes D; Geberhiwot T
    J Inherit Metab Dis; 2018 Mar; 41(2):239-247. PubMed ID: 29294190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Pathogenesis of Central and Peripheral Nervous System Complications in Anderson-Fabry Disease.
    Tuttolomondo A; Baglio I; Riolo R; Todaro F; Parrinello G; Miceli S; Simonetta I
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain related channels are differentially expressed in neuronal and non-neuronal cells of glabrous skin of fabry knockout male mice.
    Lakomá J; Rimondini R; Donadio V; Liguori R; Caprini M
    PLoS One; 2014; 9(10):e108641. PubMed ID: 25337704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of proteomic signatures associated with lung cancer and COPD.
    Pastor MD; Nogal A; Molina-Pinelo S; Meléndez R; Salinas A; González De la Peña M; Martín-Juan J; Corral J; García-Carbonero R; Carnero A; Paz-Ares L
    J Proteomics; 2013 Aug; 89():227-37. PubMed ID: 23665002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anderson-Fabry disease: a multiorgan disease.
    Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
    Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast fingerprinting by MALDI-TOF mass spectrometry of urinary sediment glycosphingolipids in Fabry disease.
    Touboul D; Roy S; Germain DP; Baillet A; Brion F; Prognon P; Chaminade P; Laprévote O
    Anal Bioanal Chem; 2005 Jul; 382(5):1209-16. PubMed ID: 15959771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide.
    De Francesco PN; Mucci JM; Ceci R; Fossati CA; Rozenfeld PA
    Mol Genet Metab; 2013 May; 109(1):93-9. PubMed ID: 23452955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.